compound C5（Dalian University of Technology）

N/A

Report date: 2023/02/27 17:35:15
NME

Base Information

Drug Namecompound C5（Dalian University of Technology）
Drug Alias Name化合物C5（大连理工大学）C-5
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionApoptosis regulator Bcl-2 degradersInduced myeloid leukemia cell differentiation protein Mcl-1 degraders
TargetsApoptosis regulator Bcl-2Induced myeloid leukemia cell differentiation protein Mcl-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDalian University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesDalian University Of Technology
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A